RankAlpha logo
Back to Rankings

VRTX

VertexB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
Earnings surprise screen
43Disqualified2026-11-02 amc

Vertex has a potentially supportive raised full-year revenue outlook and product diversification story, but the checked pre-event tape was weak over five sessions and the required positive estimate-revision and volume confirmations were not established; the available material does not support a qualifying surprise setup.

Revision
3
Revenue
5
Business
13
Price
9
Volume
3
Risk
10
Required signals: None marked positive
Preferred signals: None marked positive
Risk flags: no consensus eps or revenue source
Screen as of 2026-10-28. Window 2026-10-28 to 2026-11-03.

Setup hits (3d)

Net Bullish

3 setup hits in the last 3 trading days, 1 bullish, 0 bearish, net strength strong.

Review the highest-weight setup hits and confirm with price action before acting.

Total Hits
3
Last 3d
Bullish
1
33% of hits
Bearish
0
0% of hits
Net Bias
Net Bullish
Bullish > Bearish
Top Strength
strong
Weighted strength
Bullish setup hits
Sorted by strength
+

RA-Quality-LowBeta

Bullish screener rule firing in the current setup window.

Fresh / 3d
Strength
High
Weight
40%
Impact
High
Hits
3
Recent setup history
Date
RA-Quality-LowBeta
Bullish
Bearish
Total
10.27
Latest
1
1
0
1
10.26
1d ago
1
1
0
1
10.25
2d ago
1
1
0
1
Bullish hitBearish hit- No activity
Open full setup hits view

Setup hits are derived from RankAlpha screener rules firing within the last 3 trading days. Net bias reflects the weighted balance of bullish vs bearish hits.